Skip to main content
Hyman Muss, MD, Oncology, Chapel Hill, NC, University of North Carolina Hospitals

HymanBMussMD

Oncology Chapel Hill, NC

Professor of Medical Oncology, University of North Carolina School of Medicine

Dr. Muss is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Muss' full profile

Already have an account?

Education & Training

  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 1972 - 1974
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 1972 - 1973
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 1968 - 1970
  • State University of New York Downstate Medical Center College of Medicine
    State University of New York Downstate Medical Center College of MedicineClass of 1968

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2009 - 2025
  • VT State Medical License
    VT State Medical License 1996 - 2014
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2002-2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast Cancer  
    Aminah Jatoi, Antonio C Wolff, Harvey Jay Cohen, Rachel A Freedman, Gustav Magrinat, Julie Gralow, Gretchen Kimmick, Heidi D Klepin, Harold Burstein, Hyman Muss, Jeann..., Journal of the American Geriatrics Society

Press Mentions

  • Xeloda Still Inferior for Older Patients with Early Breast Cancer
    Xeloda Still Inferior for Older Patients with Early Breast CancerJuly 31st, 2019
  • Cancer Patients, Doctors Find Healing, Health in Exercise
    Cancer Patients, Doctors Find Healing, Health in ExerciseMay 3rd, 2019
  • Older Breast Cancer Patients Require Special Consideration
    Older Breast Cancer Patients Require Special ConsiderationSeptember 24th, 2017
  • Join now to see all

Grant Support

  • Cancer Center Calgb ParticipationNational Cancer Institute1998–2002
  • Core--Clinical Research ManagementNational Cancer Institute1997–2002
  • Modulation Of 5-FU Pharmacology By PALA And DipyridamoleNational Cancer Institute1994
  • Cccwfu Breast Cancer Research Program Planning GrantNational Cancer Institute1994
  • Modulation Of 5-FU Pharmacology By PALA &DipyridamoleNational Cancer Institute1993

Professional Memberships

Hospital Affiliations